Scientist Profile Directory

Dr. Henry A. Dunn’s research aims to elucidate the molecular mechanisms underlying neurodevelopmental and neuropsychiatric disease with the goal of facilitating the development of novel therapeutic strategies for a myriad of neurological conditions, including autism spectrum disorder (ASD), anxiety disorders, attention-deficit/hyperactivity disorder (ADHD), and epilepsy.

With a prominent focus and expertise on G protein-coupled receptors (GPCRs) and their associated signalling pathways – the pharmaceutical target of over 35% of FDA-approved drugs – Dr. Dunn’s lab utilizes multidisciplinary approaches spanning molecular mechanisms to rodent models, including: molecular pharmacology, biochemistry, cellular & molecular neurobiology, bioinformatics and behavioural neuroscience.